Potassium

Potassium

SCHEMBL29446285

C[Si](C)(C)O.[K]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27481422 0.93 ALDH1A1 (0.33)
SCHEMBL15342 0.93
SCHEMBL6135207 0.86 ALDH1A1 (0.30)
Ammonia Solution, Strong SCHEMBL7066020 0.86
SCHEMBL423855 0.86
SCHEMBL8853785 0.86 ALDH1A1 (0.30)
SCHEMBL6135760 0.86 ALDH1A1 (0.30)
SCHEMBL504312 0.86
SCHEMBL22973418 0.86
SCHEMBL3432651 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459764-A Preparation method of acrylic acid grafted modified methylphenyl polysiloxane prepolymer and application of acrylic acid grafted modified methylphenyl polysiloxane prepolymer in 3D printing photosensitive resin 泉州师范学院 2024-08-09 CN disclosed
US-20240018138-A1 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS VENTUS THERAPEUTICS U.S., INC. 2024-01-18 US disclosed
EP-4263520-A1 HETEROCYCLIC INHIBITORS OF PCSK9 Cardio Therapeutics Pty Ltd (AU) 2023-10-25 EP disclosed
EP-4216940-A1 PYRIDO[4,3-B]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS Ventus Therapeutics U.S., Inc. (US) 2023-08-02 EP disclosed
WO-2022133529-A1 HETEROCYCLIC INHIBITORS OF PCSK9 Cardio Therapeutics Pty Ltd (AU) 2022-06-30 WO disclosed
WO-2022066851-A1 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS VENTUS THERAPEUTICS U.S., INC. (US) 2022-03-31 WO disclosed